Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option. (Q40010734)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

1 reference

antibiotic resistance

1 reference

based on heuristic

inferred from title

author

Tomas Navarro-Rodriguez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

Joaquim Prado Moraes-Filho

18 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Jaime Natan Eisig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Fernando Marcuz Silva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Ricardo Correa Barbuti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

José Pedrazzoli

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

Arquivos de Gastroenterologia

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

261-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

"Rescue" regimens after Helicobacter pylori treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Efficient identification and evaluation of effective Helicobacter pylori therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Helicobacter pylori: antibiotic resistance and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032011000400008

10.1590/S0004-28032011000400008

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22147131%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference